Profil
Didier Véron is a Member-Supervisory Board at Leem.
He was a Director-Corporate Communications at Tercica, Inc. from 2012 to 2014.
He was also a SVP-Public Affairs & Corporate Communications at Ipsen SA from 2013 to 2018.
Mr. Véron has an undergraduate degree from Sciences Po and a graduate degree from Université de Paris XI Paris Sud.
Postes actifs de Didier Véron
Sociétés | Poste | Début |
---|---|---|
Leem | Directeur/Membre du Conseil | - |
Anciens postes connus de Didier Véron
Sociétés | Poste | Fin |
---|---|---|
IPSEN | Public Communications Contact | 01/12/2018 |
Tercica, Inc.
Tercica, Inc. Pharmaceuticals: MajorHealth Technology The Company's principal activity as a biopharmaceutical company is focused on the development and commercialization of products to improve endocrine health. Its first product, IncrelexTM (mecasermin {rDNA origin} injection), or recombinant human insulin-like growth factor-1 (rhIGF-1), is approved by the FDA for the treatment of severe Primary IGFD. The Company licensed the rights to develop, manufacture and commercialize Increlex from Genentech Inc. | Public Communications Contact | 03/02/2014 |
Formation de Didier Véron
Sciences Po | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 1 |
---|---|
IPSEN | Health Technology |
Entreprise privées | 3 |
---|---|
Tercica, Inc.
Tercica, Inc. Pharmaceuticals: MajorHealth Technology The Company's principal activity as a biopharmaceutical company is focused on the development and commercialization of products to improve endocrine health. Its first product, IncrelexTM (mecasermin {rDNA origin} injection), or recombinant human insulin-like growth factor-1 (rhIGF-1), is approved by the FDA for the treatment of severe Primary IGFD. The Company licensed the rights to develop, manufacture and commercialize Increlex from Genentech Inc. | Health Technology |
Leem | |
Université de Paris XI Paris Sud | Consumer Services |